New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
14:51 EDTBCRXBioCryst price target raised to $17 from $13 at JMP Securities
JMP Securities raised BioCryst's price target to $17 following proof of concept results for OPuS-1 Phase 2a trial. Shares are Outperform rated.
News For BCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 17, 2015
06:54 EDTBCRXBioCryst licenses global rights for Rapivab influenza treatment to CSL
Subscribe for More Information
June 16, 2015
10:58 EDTBCRXBioCryst drug may have elicited severe immune thrombocytopenia, report says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use